Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Biotechnology

Pharmaceutical

Therapeutics

Amgen

Robert A. Bradway

Sean Bruich

Alper Üreten

Susie Tappouni

Brenda Torres

David M. Reese

James Bradner

Narimon Honarpour

Greg Portner

Esteban Santos

Peter H. Griffith

Nancy Grygiel

Emily Razaqi

Mark J. Taisey

Jonathan Graham

Derek Miller

Linh Kha

Rachna Khosla

Murdo Gordon

Research and Development

Commercial Operations

Supply Chain Management

Information Technology and Digital Systems

Leadership Team

Quality Assurance and Compliance

Data Science and Analytics

Teams at Amgen